Loading…

Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews

Summary Background Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases. Objectives To present clinical aspects of a third FXI mutation, typ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of thrombosis and haemostasis 2013-04, Vol.11 (4), p.724-730
Main Authors: Peretz, H., Salomon, O., Mor‐cohen, R., Usher, S., Zucker, M., Zivelin, A., Seligsohn, U.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3
cites cdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3
container_end_page 730
container_issue 4
container_start_page 724
container_title Journal of thrombosis and haemostasis
container_volume 11
creator Peretz, H.
Salomon, O.
Mor‐cohen, R.
Usher, S.
Zucker, M.
Zivelin, A.
Seligsohn, U.
description Summary Background Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases. Objectives To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G>A), which is also prevalent in AJ and to discern a possible founder effect. Methods Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation. Results Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe. Conclusions The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.
doi_str_mv 10.1111/jth.12137
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1458524731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1458524731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</originalsourceid><addsrcrecordid>eNqF0UFr2zAUB3BRVtqs62FfYAh22Q5p9STLko-hNE1KoZcUdjOK9Dwrc-xUsgnZp6-ytB0USnWRePz4o8efkK_ALiCdy1VfXwAHoY7ICKTQY6VF_unlXQhxSj7HuGIMCsnZCTnlQggOWTYij4vdBumcrofe9L5rqW9pXyOdAtDf2CL1kZo08cFR01qMfTDNf72tva2pNUPESCtj-y7QX3PqsPLWY2t3-7xJrP9ga_56eovb-IUcV6aJeP58n5GH6fXiaja-u7-ZX03uxjbjoMaA2mhtUaMqCiczq5bSgdUCmdHOKRCMO8O0ckWaSa3k0jEhqhyc5oVYijPy45C7Cd3jkD5ern202DSmxW6IJWRSS54pAR9TwXPFtQSW6Pc3dNUNoU2L7JWUeZ4xldTPg7KhizFgVW6CX5uwK4GV-8rKVFn5r7Jkvz0nDss1ulf50lEClwew9Q3u3k8qbxezQ-QTFWudxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325566407</pqid></control><display><type>article</type><title>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</title><source>EZB Electronic Journals Library</source><creator>Peretz, H. ; Salomon, O. ; Mor‐cohen, R. ; Usher, S. ; Zucker, M. ; Zivelin, A. ; Seligsohn, U.</creator><creatorcontrib>Peretz, H. ; Salomon, O. ; Mor‐cohen, R. ; Usher, S. ; Zucker, M. ; Zivelin, A. ; Seligsohn, U.</creatorcontrib><description>Summary Background Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases. Objectives To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G&gt;A), which is also prevalent in AJ and to discern a possible founder effect. Methods Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation. Results Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe. Conclusions The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/jth.12137</identifier><identifier>PMID: 23332144</identifier><language>eng</language><publisher>England: Elsevier Limited</publisher><subject>Age ; Ashkenazi Jews ; factor XI ; Factor XI - genetics ; Factor XI - metabolism ; factor XI deficiency ; Factor XI Deficiency - genetics ; factor XI mutations ; Female ; Founder Effect ; Humans ; Jews - genetics ; Male ; Mutation ; Pedigree ; polymorphisms</subject><ispartof>Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.724-730</ispartof><rights>2013 International Society on Thrombosis and Haemostasis</rights><rights>2013 International Society on Thrombosis and Haemostasis.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</citedby><cites>FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23332144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peretz, H.</creatorcontrib><creatorcontrib>Salomon, O.</creatorcontrib><creatorcontrib>Mor‐cohen, R.</creatorcontrib><creatorcontrib>Usher, S.</creatorcontrib><creatorcontrib>Zucker, M.</creatorcontrib><creatorcontrib>Zivelin, A.</creatorcontrib><creatorcontrib>Seligsohn, U.</creatorcontrib><title>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Summary Background Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases. Objectives To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G&gt;A), which is also prevalent in AJ and to discern a possible founder effect. Methods Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation. Results Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe. Conclusions The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.</description><subject>Age</subject><subject>Ashkenazi Jews</subject><subject>factor XI</subject><subject>Factor XI - genetics</subject><subject>Factor XI - metabolism</subject><subject>factor XI deficiency</subject><subject>Factor XI Deficiency - genetics</subject><subject>factor XI mutations</subject><subject>Female</subject><subject>Founder Effect</subject><subject>Humans</subject><subject>Jews - genetics</subject><subject>Male</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>polymorphisms</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqF0UFr2zAUB3BRVtqs62FfYAh22Q5p9STLko-hNE1KoZcUdjOK9Dwrc-xUsgnZp6-ytB0USnWRePz4o8efkK_ALiCdy1VfXwAHoY7ICKTQY6VF_unlXQhxSj7HuGIMCsnZCTnlQggOWTYij4vdBumcrofe9L5rqW9pXyOdAtDf2CL1kZo08cFR01qMfTDNf72tva2pNUPESCtj-y7QX3PqsPLWY2t3-7xJrP9ga_56eovb-IUcV6aJeP58n5GH6fXiaja-u7-ZX03uxjbjoMaA2mhtUaMqCiczq5bSgdUCmdHOKRCMO8O0ckWaSa3k0jEhqhyc5oVYijPy45C7Cd3jkD5ern202DSmxW6IJWRSS54pAR9TwXPFtQSW6Pc3dNUNoU2L7JWUeZ4xldTPg7KhizFgVW6CX5uwK4GV-8rKVFn5r7Jkvz0nDss1ulf50lEClwew9Q3u3k8qbxezQ-QTFWudxw</recordid><startdate>201304</startdate><enddate>201304</enddate><creator>Peretz, H.</creator><creator>Salomon, O.</creator><creator>Mor‐cohen, R.</creator><creator>Usher, S.</creator><creator>Zucker, M.</creator><creator>Zivelin, A.</creator><creator>Seligsohn, U.</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201304</creationdate><title>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</title><author>Peretz, H. ; Salomon, O. ; Mor‐cohen, R. ; Usher, S. ; Zucker, M. ; Zivelin, A. ; Seligsohn, U.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age</topic><topic>Ashkenazi Jews</topic><topic>factor XI</topic><topic>Factor XI - genetics</topic><topic>Factor XI - metabolism</topic><topic>factor XI deficiency</topic><topic>Factor XI Deficiency - genetics</topic><topic>factor XI mutations</topic><topic>Female</topic><topic>Founder Effect</topic><topic>Humans</topic><topic>Jews - genetics</topic><topic>Male</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>polymorphisms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peretz, H.</creatorcontrib><creatorcontrib>Salomon, O.</creatorcontrib><creatorcontrib>Mor‐cohen, R.</creatorcontrib><creatorcontrib>Usher, S.</creatorcontrib><creatorcontrib>Zucker, M.</creatorcontrib><creatorcontrib>Zivelin, A.</creatorcontrib><creatorcontrib>Seligsohn, U.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peretz, H.</au><au>Salomon, O.</au><au>Mor‐cohen, R.</au><au>Usher, S.</au><au>Zucker, M.</au><au>Zivelin, A.</au><au>Seligsohn, U.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2013-04</date><risdate>2013</risdate><volume>11</volume><issue>4</issue><spage>724</spage><epage>730</epage><pages>724-730</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Summary Background Factor XI (FXI) deficiency is one of the most frequent inherited disorders in Ashkenazi Jews (AJ). Two predominant founder mutations termed type II (p.Glu117Stop) and type III (p.Phe283Leu) account for most cases. Objectives To present clinical aspects of a third FXI mutation, type I (c.1716 + 1G&gt;A), which is also prevalent in AJ and to discern a possible founder effect. Methods Bleeding manifestations, FXI levels and origin of members of 13 unrelated families harboring the type I mutation were determined. In addition, eight intragenic and five extragenic polymorphisms were analyzed in patients with a type I mutation, in 16 unrelated type II homozygotes, in 23 unrelated type III homozygotes and in Ashkenazi Jewish controls. Analysis of these polymorphisms enabled haplotype analysis and estimation of the age of the type I mutation. Results Four of 16 type I heterozygotes (25%) and 6 of 12 (50%) compound heterozygotes for type I mutation (I/II and I/III), or a type I homozygote had bleeding manifestations. Haplotype analysis disclosed that like type II and type III mutations, the type I is also an ancestral mutation. An age estimate revealed that the type I mutation occurred approximately 600 years ago. The geographic distribution of affected families suggested that there was a distinct origin of the type I mutation in Eastern Europe. Conclusions The rather rare type I mutation in the FXI gene is a third founder mutation in AJ.</abstract><cop>England</cop><pub>Elsevier Limited</pub><pmid>23332144</pmid><doi>10.1111/jth.12137</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-7933
ispartof Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.724-730
issn 1538-7933
1538-7836
1538-7836
language eng
recordid cdi_proquest_miscellaneous_1458524731
source EZB Electronic Journals Library
subjects Age
Ashkenazi Jews
factor XI
Factor XI - genetics
Factor XI - metabolism
factor XI deficiency
Factor XI Deficiency - genetics
factor XI mutations
Female
Founder Effect
Humans
Jews - genetics
Male
Mutation
Pedigree
polymorphisms
title Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A18%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20I%20mutation%20in%20the%20F11%20gene%20is%20a%20third%20ancestral%20mutation%20which%20causes%20factor%20XI%20deficiency%20in%20Ashkenazi%20Jews&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=Peretz,%20H.&rft.date=2013-04&rft.volume=11&rft.issue=4&rft.spage=724&rft.epage=730&rft.pages=724-730&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/jth.12137&rft_dat=%3Cproquest_cross%3E1458524731%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4217-1e8a88ce8e799d54c7b5d1c83e0a8dd71302da087d983e5875bd033f61d8293b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1325566407&rft_id=info:pmid/23332144&rfr_iscdi=true